Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients

Age: 18 years and over

Healthy Volunteers:

This study is NOT accepting healthy volunteers

Inclusion Criteria:

* Aged \> 18 years * Speak and understand English * Have received and LT

Exclusion Criteria:

* Acute cellular or chronic rejection within 3 months * Post-LT liver or non-liver related malignancy * Active viral hepatitis (B or C) or autoimmune hepatitis * Untreated biliary strictures or vascular complications (e.g. hepatic artery thrombosis) * Poorly controlled diabetes (HbA1c \>8.5%) * Relapse of alcohol use after LT * Follow a vegetarian or vegan diet * Current pregnancy * Unable to provide informed consent

Interventions:

OTHER: Experimental: EVOO

Conditions:

Liver Transplant

Contact(s): Patrice Wiecek - wiecekpj@vcu.edu

Principal Investigator:

Phase: NA

IRB Number:

System ID: NCT06043531

Thank you for choosing StudyFinder. Please visit http://studyfinder.cctr.vcu.edu to find a Study which is right for you and contact ctrrecruit@vcu.edu if you have questions or need assistance.

Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients

Email this study information to me

Contact the study team